202 related articles for article (PubMed ID: 32360526)
1. Invasive Procedural Treatments for Symptomatic Uterine Fibroids: A Cost Analysis.
Cronan J; Horný M; Duszak R; Newsome J; Carlos R; Hughes DR; Memula S; Kokabi N
J Am Coll Radiol; 2020 Oct; 17(10):1237-1244. PubMed ID: 32360526
[TBL] [Abstract][Full Text] [Related]
2. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
3. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):305-18. PubMed ID: 16001461
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Uterine fibroid embolization: CME update for family physicians.
Raikhlin A; Baerlocher MO; Asch MR
Can Fam Physician; 2007 Feb; 53(2):250-6. PubMed ID: 17872642
[TBL] [Abstract][Full Text] [Related]
7. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
[TBL] [Abstract][Full Text] [Related]
8. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
[TBL] [Abstract][Full Text] [Related]
9. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
10. Body Image and Sexual Function Improve after Both Myomectomy and Hysterectomy for Symptomatic Fibroids.
Klock J; Radakrishnan A; Runge MA; Aaby D; Milad MP
South Med J; 2021 Dec; 114(12):733-738. PubMed ID: 34853847
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
12. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
[TBL] [Abstract][Full Text] [Related]
13. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
16. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
17. Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids.
McLucas B; Adler L; Perrella R
J Am Coll Surg; 2001 Jan; 192(1):95-105. PubMed ID: 11192931
[TBL] [Abstract][Full Text] [Related]
18. What are the total costs of surgical treatment for uterine fibroids?
Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive surgery for uterine fibroids.
Wang Y; Zhang S; Li C; Li B; Ouyang L
Ginekol Pol; 2020; 91(3):149-157. PubMed ID: 32266956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
